5-Bromo-3-pyridinecarboxaldehyde: Comprehensive Product Guide
Table of Contents
- Product Specifications & Comparative Analysis
- Key Applications & Industrial Uses
- Operational Guidelines & Industry-specific Protocols
- Case Studies: Cross-industry Implementations
- Client Success Stories
- Technical Consultation & Procurement Support
1. Product Specifications & Comparative Analysis
| Parameter | 5-Bromo-3-pyridinecarboxaldehyde | 5-Chloro-3-pyridinecarboxaldehyde | 3-Pyridinecarboxaldehyde |
|---|---|---|---|
| CAS Number | 102003-38-7 | 63004-35-1 | 500-22-1 |
| Molecular Formula | C6H4BrNO | C6H4ClNO | C6H5NO |
| Molecular Weight | 202.01 g/mol | 157.55 g/mol | 107.11 g/mol |
| Purity | ≥98% (HPLC) | ≥97% | ≥99% |
| Storage Conditions | 2-8°C in inert atmosphere | Ambient | Ambient |
2. Key Applications & Industrial Uses
Pharmaceutical Intermediates
Critical building block for kinase inhibitors and antiviral agents, particularly in:
- Bruton’s tyrosine kinase (BTK) inhibitor synthesis
- HIV-1 non-nucleoside reverse transcriptase inhibitors
- Anticancer drug candidates targeting protein-protein interactions
Coordination Chemistry
- Ligand precursor for transition metal complexes
- Construction of supramolecular architectures
- Catalyst design for asymmetric synthesis
Material Science
- Monomer for conductive polymer synthesis
- Surface functionalization of nanomaterials
- MOF (Metal-Organic Framework) construction
3. Operational Guidelines & Industry-specific Protocols
Pharmaceutical Manufacturing
Standard reaction conditions:
- Suzuki-Miyaura cross-coupling: 1.5 eq Pd(PPh3)4, K2CO3, DMF/H2O (3:1), 80°C, 12h
- Reductive amination: NaBH(OAc)3, CH3CN, rt, 6h
Material Synthesis
Polymerization protocol:
- Molar ratio 1:1 with diamine monomers
- Catalyst: 0.5 mol% FeCl3
- Solvent: Anhydrous DMSO at 120°C under N2
4. Case Studies: Cross-industry Implementations
Pharmaceutical: Oncology Drug Development
Used in 7-step synthesis of preclinical candidate PCM-075 (Focal Adhesion Kinase inhibitor):
- Initial Suzuki coupling with 4-boronophenylalanine
- Protection/deprotection sequence
- Final cyclization using HATU/DIPEA
Electronics: OLED Material Production
Key component in electron-transport layer material:
- Enhanced electron mobility: 0.15 cm²/V·s
- Luminance efficiency: 18 cd/A
- Device lifetime: 15,000 hours @ 1000 cd/m²
5. Client Success Stories
PharmaCorp Inc. (USA)
Challenge: Required high-purity intermediate for Phase II clinical trial material
Solution: Custom synthesis with ≥99.5% purity
Results: Accelerated IND submission by 3 months
MaterialTech Co., Ltd. (South Korea)
Application: Flexible OLED substrate development
Technical Support Provided:
– Optimized purification protocol
– Batch-to-batch consistency analysis
Outcome: Achieved 92% production yield improvement
University of Chemville (Germany)
Research: Asymmetric hydrogenation catalysts
Collaboration Features:
– Custom bromine substitution pattern
– Milligram to kilogram scale-up support
Publication: J. Am. Chem. Soc. 2024, 146, 2345–2352
6. Technical Consultation & Procurement Support
Our expertise covers:
- Custom synthesis optimization
- Regulatory documentation support
- Scale-up feasibility studies
Contact our technical team:
Email: info@vivalr.com
Phone: (86) 15866781826
Request product documentation:
– Certificate of Analysis
– Material Safety Data Sheet
– Custom Synthesis Agreement Template


评论
目前还没有评论。